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Acute Coronary Syndrome
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Ticagrelor Versus Clopidogrel in African American Patients with Stable Coronary Artery
Disease: A Randomized, Open-label, Multiple-dose, Crossover Study
R. Waksman,1 J. Maya,2 D. J. Angiolillo,3 G. Carlson,2 R. Teng,2 R. Caplan,2
K. Ferdinand4
1Washington Hospital Center, Washington, DC; 2AstraZeneca LP, Wilmington, DE;
3University of Florida, Jacksonville, FL; 4Tulane University, New Orleans, LA
Background: The pivotal PLATelet inhibition and Patient Outcomes (PLATO)
study evaluated ticagrelor vs clopidogrel for reduction of thrombotic events in patients
with acute coronary syndrome. African Americans (AAs) have a high mortality rate
from coronary artery disease (CAD). However, their participation in clinical studies is
limited. The aim of the present study was to compare the pharmacodynamics (PD) of
ticagrelor vs clopidogrel in AAs with stable CAD.
Methods: A multicenter, randomized, open-label, crossover PD study was conducted
in aspirin (75–100mg/day) treated AA patients with stable CAD. Patients were
randomized to receive either ticagrelor (180 mg loading dose [LD] followed by 90 mg
twice-daily maintenance dose [MD] for 7–9 days) or clopidogrel (600 mg LD fol-
lowed by 75 mg once-daily MD for 7–9 days). After a 10–14 day washout period,
patients crossed over therapy. Platelet reactivity was measured with the VerifyNow
P2Y12 function assay at the following time-points: 0.5, 2 and 8h following LD and 0,
2, 8 and 12–24h following MD.
Results: A total of 34 AA patients were randomized. At all post-dose time points,
on-treatment platelet reactivity was lower for ticagrelor versus clopidogrel (Figure).
Conclusions: In AA patients with stable CAD on daily low-dose aspirin, ticagrelor
provided a faster onset and greater extent of platelet inhibition than clopidogrel.*Indicates iMPACT Trial Accepted for Oral PresentationCRT-100
A Systematic Diagnostic and Therapeutic Approach for the Treatment of Patients After
Cardio-Pulmonary Resuscitation: A Prospective Evaluation of 212 Patients During 5
Years
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Background: There is a need for a systematic treatment protocol for patients after
resuscitation.
Methods: A systematic diagnostic approach including ECG, echocardiogram, urgent
cardiac catheterization (“STEMI-like” workﬂow), pulmonary angiography, CT scans,
pre-deﬁned laboratory ﬁndings, IABP, hypothermia and cMRI prospectively during
the last 5 years was in our cardiology department evaluated. The primary endpoint was
the Cerebral Performance Category Scale (CPCS).
Results: From January 2008 to December 2012, 212 patients were included into our
protocol. Mean age was 66.7 years, 71.2 % were male, the mean ejection fraction was
42.9 %, the mean time from ﬁrst medical contact to start of catheterization/inter-
vention was 76.6 minutes. Ventricular ﬁbrillation (VF) was observed in 99 patients
reﬂecting 46.7 %. A signiﬁcant coronary artery stenosis (deﬁned as % stenosis > 60 %)
was found in n¼130 (61.3 %) and a percutaneous coronary intervention (PCI) was
performed in 101 patients (47.6 %). An acute coronary syndrome (ACS) was diag-
nosed in 100 patients (47.2 %), 91 patients (42.9 %) had a cardiomyopathy, and
7 patients (3.3 %) had evidence for a Tako-Tsubo cardiomyopathy. Rare diagnoses
were patients with pulmonary embolism (n¼8, 3.8 %), a vitium cordis or a congenital
defect (n¼ 4, 1.9 %), a long QT syndrome (n¼ 4, 1.9 %), an early repolarization
syndrome (n¼ 2, 0.9 %), hypertrophic cardiomyopathy (n¼ 1, 0.5 %) and aortic
dissection (n¼1, 0.5 %). A mechanical recanalization of a large thrombus of the
pulmonary artery was performed in one patient. An extracardiac cause for cardiac arrest
was observed in 12 patients (5.7 %) and mostly secondary to stroke (cerebral infarction/
bleeding).
Endpoints: The survival rate was n¼76 (35.9 %), a CPCS of 1/2 was established in 67
patients (31.8 %). In patients being treated with a PCI, a signiﬁcant difference in
mortality was found for patients with TIMI ﬂow 2/3 vs 0/1 (65.4 % vs. 95.7, p< 0.05).
The difference in mortality with respect to intra-aortic balloon pumping vs. no
pumping was not statistically signiﬁcant (70.0 % vs. 63.6 %, p¼0.6). Hypothermia was
able to reduce mortality signiﬁcantly (52.7 % vs 68.2 %, p<0.05).
Conclusion: A systematic diagnostic and therapeutic algorithm using a “STEMI-like”
workﬂow which includes urgent catheterization is feasible, safe and can improve
prognosis.
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Cocaine Paradox: A Predictor of Myocardial Infarction, Not Premature CAD
Kalgi Modi, Shivang Shah, Naga Vutukuri, Joshua Jordan
LSUHSC, SHV, LA
Background: In the present study we aim to evaluate major predictors of premature
coronary artery disease (PCAD) in patients aged  35 years undergoing coronary
angiography for acute coronary syndrome.
Methods: We evaluated 224 consecutive patients aged  35 years who underwent
coronary angiography at our institution between years 2003 to 2012. For each patient,
demographics, coronary risk factors such as-family history of PCAD, hypercholes-
terolemia, diabetes mellitus, hypertension, cigarette smoking, cocaine use, biochemical
proﬁle and angiographic ﬁndings were recorded. Patients were divided into two group
1) signiﬁcant CAD  50% stenosis and 2) No or Non-signiﬁcant CAD. These two
groups were compared and data was analyzed using SPSS 16.
Results: Out of 224 patients, 64 had signiﬁcant CAD and the remaining 160 had no
or non-signiﬁcant CAD. Prevalence of smoking was found to be signiﬁcantly higher in
the signiﬁcant CAD group as compared to the no or non signiﬁcant disease group
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with signiﬁcant CAD had an elevated White blood cell count (m place¼ 128.75) as
compared to the patients in the no or non signiﬁcant disease group (m place¼97.87,
U¼3355.00, p¼0.001) The signiﬁcant CAD group also had higher random blood
sugar (m place¼131.48) as compared to the patients in the no or non signiﬁcant
disease group (m place¼98.49, U¼3287.50, p<0.001). In a subgroup of patient with
myocardial infarction, the odds of having used cocaine was 4.92(CI¼1.37, 17.71)
times higher than the patients without myocardial infarction (c2(df¼1) ¼6.48,
p¼0.013). However, overall there was no difference in the prevalence of cocaine use in
the signiﬁcant CAD group as compared to the non-signiﬁcant CAD (c2 (df¼1)
¼.292, p¼0.059).
Conclusion: 28.57% of patients under age < 35 years undergoing coronary angiog-
raphy had signiﬁcant CAD. PCAD was signiﬁcantly associated with smoking, hy-
perglycemia, and leukocytosis. 3) Smoking continues to be an important and
modiﬁable risk factor associated with PCAD. 4) Cocaine use in young patients is
associated with higher incidence of myocardial infarction but is not a predictor of
PCAD.
CRT-102
Non ST Segment Elevation Myocardial Infarction Due to Complete Coronary Occlusion:
Clinical Characteristics
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Objective: Routine electrocardiogram is unable to detect ST elevation in all patients
who present with myocardial infarction due to acute total coronary occlusion. Our aim
was to evaluate the incidence, distribution of the involved vessel and extent of cardiac
injury in patients with non-ST elevation myocardial infarction (NSTEMI) who have
acutely occluded infarct related artery (IRA).
Methods: Total occlusion of IRA was evaluated in 535 consecutive patients who
presented with NSTEMI and underwent angiography. Patients were divided into
groups based on the distribution of the occluded vessel; infero-lateral (left circumﬂex
and right coronary artery) and anterior distribution (left anterior descending). De-
mographic and clinical characteristics were compared between these groups. The
extent of cardiac injury was measured by the peak level of cardiac enzymes.
Results: The IRA was completely occluded in 78 (15%) of patients. The median time
from presentation to coronary intervention was 18 hours. The occluded vessels were
more common in the infero-lateral (73%) as compared to the anterior (27%) distri-
bution. There was no signiﬁcant difference between the two groups (Table 1).
Conclusions: About 15% of NSTEMI are due to a totally occluded artery; more
commonly in the infero-lateral distribution. These patients represent STEMI equiv-
alents and likely beneﬁt from an early invasive strategy. There is need for better triage
and earlier identiﬁcation of these subgroups.
Table 1. Baseline Characteristics Stratiﬁed by Occluded Artery DistributionCharacteristics
Anterior
(n ¼ 21, 27%)
Infero-lateral
(n ¼ 57, 73%) P valueAge, yrs 57.1  9.9 59.5  12.8 0.452
Systolic Blood Pressure, mmHg 126.4  33.3 137.8  37.5 0.546
Diabetes, % 52.4 52.6 0.836Hypertension, % 76.5 75.5 0.878TIMI Score at presentation 3.2  1.2 3.0  1.0 0.522
Peak CK-MB, (Median, 25th
and 75th Percentile)
73 (18, 238) 117 (19, 196) 0.952Peak Troponin, (Median, 25th
and 75th Percentile)11 (3, 31) 12 (4, 47) 0.670Ejection Fraction, (Median, 25th
and 75th Percentile45 (40, 52) 50 (30, 55) 0.627Difference between means and medians compared by t-test and Matt-Whitney test respectively.CRT-103
Racial Disparity in Patients Undergoing Percutaneous Coronary Intervention for Acute
Coronary Syndrome: Is it Gender Dependent?
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Background: Previous studies have shown a relation between female gender and
African-American (AA) race to the adverse outcomes after percutaneous coronary inter-
vention (PCI).This study aimed to compare the one-year clinical outcomes of patients that
underwent PCI for acute coronary syndrome (ACS) stratiﬁed by the race and gender.
Methods: A cohort of 2588 patients who presented with ACS and underwent PCI
from our institutional PCI registry was recorded and analyzed based on stratiﬁcation
for gender and race. Patients were followed for 1-year and the major adverse cardiac
events (MACE), including death, Q-wave myocardial infarction, and target vessel
revascularization was recorded. A multivariable Cox proportional hazards regression to
adjust for confounding variables was performed to assess the contribution of the race
and gender with the one-year outcomes.
Results: Both AA males and females had higher prevalence of cardiovascular risk
factors compared to Caucasians. As a group AA patients had worse one-year MACE
rates when compared to Caucasians (20.5% vs. 16%, p¼0.004). AA also noted to have
higher rate of deﬁnite stent thrombosis (2.1% vs. 0.5%, p<0.001) compared to
Caucasians. In a multivariate adjusted model relative to white males, both white fe-
males and AA males had higher 1-year adjusted MACE but not AA females (Cau-
casians female: HR, 1.54; 95% CI 1.17-2.02; AA males: HR, 1.46; 95% CI 1.09-1.95;
AA females: HR, 1.11, 95% CI 0.79-1.55). Similar results were noted with regards to
death and death or myocardial infarction.
Conclusion: Though AA patients were known to have worse long term cardiovascular
outcomes compared to Caucasians this disparity is mostly driven by worse outcomes in
AA males but not AA females after adjusting for the differences in the baseline
characteristics.CRT-104
Grace Score and the Angiographic Severity of Coronary Artery Disease in Patients with
Non-ST-Elevation Acute Coronary Syndrome
Ahmed El Mahmoudy Nayel, Sameh Sabet
Ain-Shams University, Cairo, Egypt
Background: Patients hospitalized due to non-ST-elevation acute coronary syn-
dromes (ACS) have a wide variation in their disease severity, which ranges according
to clinical and laboratory characteristics. the GRACE risk score is one of most accurate
way to risk stratify patients which is essential for the clinical decision and for
discriminating patients who beneﬁt from more aggressive strategies. The relation
between the clinical risk scores and the anatomical severity of coronary artery disease
(CAD) in patients with ACS has not been established.
Objective: To assess the relation between GRACE score and severity coronary artery
disease in patients with non-ST-elevation ACS undergoing coronary angiography.
Methods: 100 patients meeting the objective criteria for NSTEMI and undergoing
coronary angiography during hospitalization were consecutively enrolled. Patients were
